Review Article

The Role of Normothermic Perfusion in Liver Transplantation (TRaNsIT Study): A Systematic Review of Preliminary Studies

Table 5

Posttransplant outcomes of included studies.

StudyPNF (%) (NMP vs Control)EAD (%) (NMP vs Control)ICU stay days edian (range (NMP vs Control)Hospital stay days edian (range (NMP vs Control)Major Complications (Clavien-Dindo ≥ 3b) (%) (NMP vs Control)Biliary Complications (6 months) NMP (%)

Ravikumar et al. [39]0 (0) vs 0 (0) ()3 (15) vs 9 (22.5) ()3.0 (1–8) vs 3 (1–41) ()12.0 (6–34) vs 14.0 (8–88) ()NA4 (20)

Selzner et al. [42]0 (0) vs 0 (0) ()NA1.0 (0–8) vs 2 (0–23) ()11.0 (8–17) vs 13.0 (7–89) ()1 (10) vs 7 (23) ()0 (0)

Bral et al. [43]0 (0) vs 0 (0) ()5 (55.5) vs 8 (29.6) ()16.0 (2–65) vs 4 (1–29) ()11.0 (8–17) vs 13.0 (7–89) ()2 (22) vs 10 (37) ()0 (0)

Liu et al. [44]NA1 (10%) vs 15 (36.8%) ()NANANANA

Nasralla et al. [45]1 (0.8) vs 0 (0) ()12 (10.1%) vs 29 (29.9%) ()4 (2–7) vs 4 (3–7) ()15 (10–24) vs 15 (11–24) ()21 (16.4) vs 36 (22) ()13 (10.1)

PNF: primary nonfunction; EAD: early graft dysfunction; ICU: intensive care unit; NA: not available.